Rhythm (Nasdaq: IRTC) today announced new results supporting its Zio long-term continuous monitoring (LTCM) ECG patch.

A familiar name in medtech is taking over the corner office at one of the world’s largest diabetes technology developers, ...

HistoSonics today announced 12-month follow-up clinical data from its prospective HOPE4LIVER trials evaluating its ...

Abbott (NYSE: ABT) today announced data from an acute clinical feasibility study of its Aveir Conduction System Pacing (CSP) ...

Medtronic (NYSE: MDT) today announced positive clinical outcomes from two studies of its pulsed field ablation (PFA) ...

Johnson & Johnson MedTech announced positive three-month results from a study evaluating its investigational Omnypulse ...

Boston Scientific today shared new clinical data supporting multiple therapies at the Heart Rhythm Society (HRS) 2025 Meeting ...

Medtronic (NYSE:MDT) announced today that it recently submitted its Hugo surgical robot platform to the FDA for a urologic ...

Medtronic (NYSE: MDT) announced that it received FDA approval for its OmniaSecure defibrillation lead for right ventricle ...

Abbott (NYSE: ABT) today announced new study data demonstrating the safety and efficacy of its Volt pulsed field ablation ...

This marks the latest recall-related issue for HeartMate in recent years. Last June, the FDA deemed another recall as serious ...

Medtronic (NYSE: MDT) announced a strategic agreement to distribute Dragonfly Endoscopy's Dragonfly pancreaticobiliary system ...